Alexander's Restructures $300M Mortgage Loan
Alexander's restructured the $300M mortgage loan on the retail condominium of 731 Lexington Avenue in Manhattan. Under the terms of the restructuring, the existing loan was split into a $132.5M senior "A-Note" accruing current interest at 7.00% per annum and a $167M junior "C-Note" accruing interest at 4.55% per annum, with a new maturity date of December 23. At the closing of the restructuring, an affiliate of Alexander's purchased the $132.5M senior A-Note from the existing lenders at par. The Alexander's affiliate also entered into a new "B-Note" with the borrower, pursuant to which funds that are loaned to the borrower, for capital and re-leasing expenses, and to fund interest on the A-Note, accrue interest at 13.5% per annum, except for loan amounts above $65M used to pay interest on the A-Note, which accrue at 7.00%.
Trade with 70% Backtested Accuracy
Analyst Views on ALX
About ALX
About the author

- Quarterly Dividend Declaration: Alexander's has declared a quarterly dividend of $4.50 per share, consistent with previous distributions, reflecting the company's stable cash flow and commitment to shareholder returns.
- Dividend Yield: The forward yield of 7.21% makes this dividend attractive to income-seeking investors, enhancing the company's appeal in the small-cap market.
- Dividend Payment Timeline: The dividend is payable on May 29, with a record date of May 11 and an ex-dividend date also on May 11, ensuring shareholders receive timely returns.
- Asset Sale Plan: Alexander's plans to sell Rego Park I for net proceeds of $202 million, which will further enhance the company's financial flexibility and support future investment opportunities.
- Quarterly Dividend Announcement: Alexander's, Inc. Board of Directors declared a quarterly dividend of $4.50 per share, payable on May 29, 2026, indicating the company's stable cash flow and commitment to shareholder returns.
- Shareholder Record Date: The record date for the dividend payment is set for May 11, 2026, ensuring that shareholders must hold shares by this date to receive the dividend, reflecting the company's focus on shareholder interests.
- Real Estate Investment Trust: As a real estate investment trust, Alexander's, Inc. owns five properties in New York City, highlighting its investment strategy in high-value markets and enhancing the stability of its asset portfolio.
- Forward-Looking Statements: The company noted that future performance may be affected by interest rate fluctuations and inflation, emphasizing the potential impact of market uncertainties on its financial condition and reminding investors to consider risk factors.
- Transaction Value: Alexander has agreed to sell its Rego Park I property to Northwell Health for $235.5 million, expecting net proceeds of approximately $202 million, which will significantly enhance the company's financial position.
- Financial Gains: The transaction is projected to generate a financial statement gain of about $147 million and a tax gain of roughly $145 million, with $48 million recognized in 2025 and about $97 million in 2026, further boosting the company's profitability.
- Timeline for Closure: The sale is expected to close by the third quarter of 2026, subject to customary closing conditions, providing the company ample time to optimize its financial and operational strategies.
- Market Impact: This property sale not only brings substantial cash flow to Alexander but also has the potential to enhance its standing in the small-cap market, attracting more investor attention to its future growth prospects.
- Quarterly Net Income Decline: In Q4 2025, Alexander's reported a net income of $3.8 million, or $0.74 per diluted share, a significant drop from $12.3 million and $2.39 in Q4 2024, indicating challenges in market conditions and reduced profitability.
- Annual Financial Performance Decline: For the year ended December 31, 2025, net income was $28.2 million, or $5.50 per diluted share, down from $43.4 million and $8.46 in 2024, highlighting ongoing pressures on revenue and earnings.
- FFO Metrics Decline: The funds from operations (FFO) for Q4 2025 stood at $12.5 million, or $2.43 per diluted share, a sharp decrease from $20.8 million and $4.06 in the same quarter of 2024, reflecting operational efficiency and asset management challenges.
- Overall Revenue Decrease: Total revenue for 2025 was $213.2 million, down from $226.4 million in 2024, indicating a negative impact from changing market conditions on the company's performance, suggesting a need for strategic reassessment to address future challenges.
Financial Performance: Alexander's has announced its financial results for the fourth quarter, highlighting key metrics and performance indicators.
Revenue and Earnings: The report details revenue figures and earnings per share, showcasing the company's financial health and growth compared to previous quarters.
- Company Performance: Alexander's Q4 adjusted FFO per share is reported at USD 2.43.
- Financial Overview: The financial results indicate a strong performance in the fourth quarter, reflecting the company's operational efficiency.






